Cargando…
Inhibition of cancer stem cell like cells by a synthetic retinoid
Developing novel drugs that can abrogate the growth and metastasis of malignant tumors is a major challenge for cancer researchers. Here we describe a novel synthetic retinoid, namely WYC-209, which inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs), known to resist...
Autores principales: | Chen, Junwei, Cao, Xin, An, Quanlin, Zhang, Yao, Li, Ke, Yao, Wenting, Shi, Fuchun, Pan, Yanfang, Jia, Qiong, Zhou, Wenwen, Yang, Fang, Wei, Fuxiang, Wang, Ning, Yu, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895803/ https://www.ncbi.nlm.nih.gov/pubmed/29643385 http://dx.doi.org/10.1038/s41467-018-03877-7 |
Ejemplares similares
-
Synthetic Retinoid Kills Drug‐Resistant Cancer Stem Cells via Inducing RARγ‐Translocation‐Mediated Tension Reduction and Chromatin Decondensation
por: Zhang, Yao, et al.
Publicado: (2022) -
Synthetic Retinoid Kills Drug‐Resistant Cancer Stem Cells via Inducing RARγ‐Translocation‐Mediated Tension Reduction and Chromatin Decondensation (Adv. Sci. 31/2022)
por: Zhang, Yao, et al.
Publicado: (2022) -
Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway
por: Qi, Feng, et al.
Publicado: (2021) -
Efficient extravasation of tumor-repopulating cells depends on cell deformability
por: Chen, Junjian, et al.
Publicado: (2016) -
Neurogenesis in Response to Synthetic Retinoids at Different Temporal Scales
por: Haffez, Hesham, et al.
Publicado: (2017)